Treatment Options

What can you expect from ORTHOVISC®/MONOVISC® High Molecular Weight Hyaluronan knee injections?

Find out what to expect during an Orthovisc/Monovisc knee injection procedure and what to expect post injection procedure. Getting you back to your passion is our passion.
 
Find Out What You Can Expect

When exercise and simple pain medications no longer effectively manage knee pain caused by osteoarthritis (OA), hyaluronic acid injections may help. These FDA-approved injections may provide up to six months of knee pain relief. Studies have shown that these injections may assist in joint pain relief and restore the cushioning and lubricating properties of your knee joint. 1

Read more  

ORTHOVISC® High Molecular Weight Hyaluronan is an FDA-approved, non-drug therapy made from ultra-pure natural hyaluronan, a naturally occurring lubricant found in healthy knee joints. ORTHOVISC® High Molecular Weight Hyaluronan may provide up to six months of pain relief. Talk to your doctor to see if ORTHOVISC® High Molecular Weight Hyaluronan might be a good choice for knee pain relief if you are not ready for total knee replacement.

ORTHOVISC® High Molecular Weight Hyaluronan is given as an injection into your knee joint (administered by a health professional) once a week for three or four consecutive weeks. After three injections, studies have shown pain relief that lasts for up to six months. 2 Although individual results vary, some people feel relief after the first injection.

Hyaluronic acid injections are a type of osteoarthritis injection treatment known as viscosupplementation, which is basically the reintroduction of healthy joint fluid into your knee. Viscosupplementation helps return proper cushioning and lubrication function to the knee joint, addressing knee pain at the source of the problem and providing relief.

Less  

What happens after an injection of ORTHOVISC®/MONOVISC High Molecular Weight Hyaluronan?

 
 

Learn about single-injection MONOVISC® High Molecular Weight Hyaluronan

 
 
References
DSUS/MTK/0115/0411c 9/2016

Find a doctor near you

Find A Doctor  

IMPORTANT SAFETY INFORMATION

High Molecular Weight Hyaluronan is indicated in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. In clinical studies, the most commonly reported adverse events for ORTHOVISC® High Molecular Weight Hyaluronan were arthralgia, back pain, and headache. Other side effects included local injection site adverse events. In clinical studies, the most commonly reported adverse events for MONOVISC® High Molecular Weight Hyaluronan were arthralgia, joint swelling and injection site pain.

ORTHOVISC® and MONOVISC® High Molecular Weight Hyaluronan are contraindicated in patients with known hypersensitivity to hyaluronate formulations or known hypersensitivity (allergy) to gram positive bacterial proteins. ORTHOVISC® and MONOVISC® High Molecular Weight Hyaluronan should not be injected in patients with infections or skin diseases in the area of the injection site or joint. MONOVISC® High Molecular Weight Hyaluronan should not be administered to patients with known bleeding disorders. Intra-articular injection of sodium hyaluronate preparations has occasionally been associated with allergic/anaphylactic reactions and transient hypotension, which have generally resolved spontaneously or after conservative treatment.